Home
Mobile version
spiked plus
About spiked
What is spiked?
Support spiked
spiked shop
Contact us
Advertising
Summer school
Top issues
Abortion
Arab uprisings
British politics
Child abuse panic
Economy
Environment
For Europe, Against the EU
Free speech
Jimmy Savile scandal
Nudge
Obesity
Parents and kids
Population
USA
View all issues...
special feature
The Counter-Leveson Inquiry
other sections
 Letters
 Review of Books
 Monthly archive
selected authors
Duleep Allirajah
Daniel Ben-Ami
Tim Black
Jennie Bristow
Sean Collins
Dr Michael Fitzpatrick
Frank Furedi
Helene Guldberg
Patrick Hayes
Mick Hume
Rob Lyons
Brendan O’Neill
Nathalie Rothschild
James Woudhuysen
more authors...
RSS feed
survey

abc def ghi jkl mno pqrs tuv wxyz index
Survey home
First thoughts
Final thoughts
Survey responses
RSS feed
Michael Baum
Gustav Born
K Eric Drexler
Marcus du Sautoy
Harold Kroto
Paul Lauterbur
Leon Lederman
Bernard Lovell
Sophie Petit-Zeman
Ingo Potrykus
Jack Pridham
Simon Singh
Jack Steinberger
Tipu Aziz
professor of neurosurgery at the University of Oxford, founder of Oxford Functional Neurosurgery, and scientific adviser to Pro-Test


Some of my earliest childhood memories are being taken by my father to his laboratory and clinics in Minnesota, when he was working towards his PhD in the functions of the liver. I learned that science was intrinsically part of medical developments.

I went to University College London to do a degree in physiology, and I was fascinated by the fact that neurosurgical procedures could restore normality in sufferers of in Parkinson’s disease. I decided to go into medicine at King’s College London, and to make such procedures my career as a neurosurgeon, and combining neurosurgery with neurophysiology.

By the time I entered neurosurgery, such procedures were rarely if ever done. Primate studies at the time suggested that lesioning the subthalamic nucleus might alleviate Parkinson’s disease. I therefore went to Manchester, to pursue a doctorate in medicine studying such lesions in the Parkinsonian primate. These lesions caused total reversal of the symptoms.

Such observations, and observations from other groups, led to deep brain stimulation of the subthalamic nucleus for Parkinson’s disease within two years. To date 40,000 patients worldwide have had such procedures done.

Today, I continue to combine neurosurgery with physiology in humans and primates. We have shown that deep brain stimulation of a new target, the pedunculopontine nucleus, can reverse gait and postural disorders in primates. Today, this is done clinically.